medigraphic.com
ISSN 1405-0315 (Print)

2003, Number 1

<< Back Next >>

Rev Mex Enf Cardiol 2003; 11 (1)

Systemic vasculitis

Collinao RM

Language: Spanish
References: 26
Page: 26-31
PDF size: 68.73 Kb.


ABSTRACT

The term Vasculitis is comprised by a group of conditions or syndromes which are characterized by the inflammation and necrosis of blood vessel walls. Systemic Vasculitis can constitute a highly heterogeneous group of pathologies that can range from auto limited benign processes to life-threatening ones. It’s clinical manifestation, treatment and prognosis depends upon the extent and location of the lesion as much as particular vessel involved. Recent studies have shown that despite many advances in the field, Systemic Vasculitis is a chronic pathology in which patients who suspend their treatment are bound to suffer a resurgence of the disease. Currently an extensive amount of research is being done in order to better treatment with less toxic medications, alternative therapies, by trying to decide exactly when immunosuppressive treatment is really necessary therefore bettering the quality of life at the patient. This article reviews and basic concepts and treatment guidelines for systematic Vasculitis based on the International Consensus Conference of Chapel Hill, North Carolina, United States, 1993.


REFERENCES

  1. Rodríguez VV. Vasculitis sistémicas. Concepto etiopatogenia y clasificación. Tratado de Reumatología. Pascual GE y col. Cap. 3.14: Aran Ediciones S.A, 1998: 633-56.

  2. Cid MC. Tratamiento de las vasculitis sistémicas. Reumatología 2000; 16(4): 131-138.

  3. Foci AS, Hoydens BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunology and therapeutic considerations. Ann Intern Ed 1978; 80: 399-409.

  4. Gross WL. New concepts in treatment protocols for severe systemic vasculitis. Curr Opin Rheumatol 1999; 11: 41-46.

  5. Jennette JC, Falk RJ. Small vessel vasculitis. N Engl J Med 1997; 337: 1512-1523.

  6. Jennette JC, Foik RJ, Andrassy K, Bacon PA, Churg J, Gross WL. Nomenclature of systemic vasculitides: Proposal of an International Consensus Conference. Arthritis Rheum 1994; 17(2): 187-92.

  7. Holsinger DR, Osmundson PJ, Edwards JE. The heart in periarteritis nodosa. Circulation 1962; 25: 610-8.

  8. Wainstein GE. Inmunopatogenia de las vasculitis. Reumatología 1998; 14(2): 71-73.

  9. Sneller MC, Fauci AS. Pathogenesis of vasculitis syndromes. The Medical Clinics of North America. Reumatología 1997; 81: 221-242.

  10. Hoffman GS, Kerr G, Lecivitt RY, Hailcihan MS, Lebovics RS, Trovis WD, Rottem M, Fauci AS. Wegener’s granulomatosis. Ann Intern Med 1992; 116: 488-498.

  11. Velásquez X, Vargas A, Radrigán F. Infarto agudo al miocardio en dos pacientes con vasculitis (Abstract No. 18). Reumatología 2000; 16(4): 169.

  12. Guillevin L, Lhote F, Gayrciud M, Cohen P, Jarrouse B, Lortholary O. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study of 342 patients. Medicine (Baltimore) 1996; 75: 17-28.

  13. Guillevin L, Cohen P, Gciyraud M, Lhote F, Jarrouse B, Casassus P. Churg-Strauss syndrome. Clinical study and longterm follow-up of 96 patients. Medicine 1999; 78: 26-37.

  14. Exley AR, Bacon PA. Clinical disease activity in systemic vasculitis. Curr Opin Rheumatol 1996; 8: 12-18.

  15. Whiting-O’Keefe QE, Stone JH, Heliman DB. Validity of a vasculitis activity index for systemic necrotizing vasculitis. Arthritis Rheum 1999; 42: 2365-71.

  16. Kerr GS, Hallahan CW, Giordano J L R F A R M H m G. Takayasu’s arteritis. Ann Intern Med 1994; 120: 919-929.

  17. Hoffman GS. Takayasu arteritis: lessons from the American National Institutes of health experience. Int J Cardiol 1996; 54(suppl): S99-S102.

  18. Leung DYM, Schilevert PM, Meissner HC. The immunopathogenesis and management of Kawasaki’s syndrome. Arthritis Rheum 1998; 4: 1538-1547.

  19. Jacobs JC. Kawasaki disease. Curr Opin Rheumatol 1996; 8: 41-43.

  20. Joyne DR, Davies MJ, Fox CJV, Block CM, Lockwood CM. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1999; 337: 1137-1139.

  21. Shrador ML, Hochman JS, Bulkley B. The heart in polyarteritis nodosa: a clinicopathologic study. Am Heart Journal 1985; 109: 1353-5.

  22. Parrillo JE, Fauci AS. Necrotizing vasculitis, coronary angiitis, and the cardiologist. Am Heart Journal 1980; 99(5): 545-54.

  23. Chu KH, Menapace FJ, Blankenship JC, Hausch R, Harrington T. Polyarteritis nodosa presenting as acute myocardial infarction with coronary dissection. Cathet Cardiovasc Diagn 1998;,44(3): 320-4.

  24. Gatenby PA, Lytton DG, Bulteau VG, O’Reilly B, Basten A. Myocardial infarction in Wegener’s granulomatosis. Aust N Z J Med 1976; 6(4): 336-40.

  25. Papo. Br J Rheumatology 1996.

  26. Pick RA, Glover MU, Vieweg WV. Myocardial infarction in a young woman with isolated coronary arteritis. Chest 1982; 82(3): 378-80.




2020     |     www.medigraphic.com